Trial Profile
The Real World Study of Apatinib for Gastric Cancer Treatment in Anhui Province
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Sep 2020
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 03 Sep 2020 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified September 2017).
- 19 Jan 2019 Results (n=679) presented at the 2019 Gastrointestinal Cancers Symposium
- 10 Nov 2017 New trial record